IL67208A - Derivatives of 7-(2-(2-amino-4-thiazolyl)-2-oxyimino-acetamido)3-pyridinium thiomethyl-3-cephem-4-carboxylic acid,their preparation and pharmaceutical compositions containing them - Google Patents

Derivatives of 7-(2-(2-amino-4-thiazolyl)-2-oxyimino-acetamido)3-pyridinium thiomethyl-3-cephem-4-carboxylic acid,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL67208A
IL67208A IL67208A IL6720882A IL67208A IL 67208 A IL67208 A IL 67208A IL 67208 A IL67208 A IL 67208A IL 6720882 A IL6720882 A IL 6720882A IL 67208 A IL67208 A IL 67208A
Authority
IL
Israel
Prior art keywords
oxyimino
cephem
acetamido
thiazolyl
derivatives
Prior art date
Application number
IL67208A
Other languages
English (en)
Other versions
IL67208A0 (en
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL67208A0 publication Critical patent/IL67208A0/xx
Publication of IL67208A publication Critical patent/IL67208A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Carbon Steel Or Casting Steel Manufacturing (AREA)
IL67208A 1981-11-16 1982-11-09 Derivatives of 7-(2-(2-amino-4-thiazolyl)-2-oxyimino-acetamido)3-pyridinium thiomethyl-3-cephem-4-carboxylic acid,their preparation and pharmaceutical compositions containing them IL67208A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8121385A FR2516515A1 (fr) 1981-11-16 1981-11-16 Nouveaux derives de pyridinium thiomethyl cephalosporines, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
IL67208A0 IL67208A0 (en) 1983-03-31
IL67208A true IL67208A (en) 1986-03-31

Family

ID=9264025

Family Applications (1)

Application Number Title Priority Date Filing Date
IL67208A IL67208A (en) 1981-11-16 1982-11-09 Derivatives of 7-(2-(2-amino-4-thiazolyl)-2-oxyimino-acetamido)3-pyridinium thiomethyl-3-cephem-4-carboxylic acid,their preparation and pharmaceutical compositions containing them

Country Status (28)

Country Link
US (1) US4593022A (es)
EP (1) EP0088853B1 (es)
JP (1) JPS5890590A (es)
KR (1) KR880001816B1 (es)
AT (1) ATE25847T1 (es)
AU (1) AU566027B2 (es)
CA (1) CA1201432A (es)
CS (1) CS232740B2 (es)
DE (1) DE3275649D1 (es)
DK (1) DK499382A (es)
EG (1) EG15642A (es)
ES (3) ES8401082A1 (es)
FI (1) FI74710C (es)
FR (1) FR2516515A1 (es)
GR (1) GR76748B (es)
HU (1) HU187812B (es)
IE (1) IE54068B1 (es)
IL (1) IL67208A (es)
MA (1) MA19644A1 (es)
NO (1) NO823740L (es)
NZ (1) NZ202493A (es)
OA (1) OA07253A (es)
PL (3) PL136099B1 (es)
PT (1) PT75854A (es)
SG (1) SG2289G (es)
SU (3) SU1165236A3 (es)
YU (1) YU253782A (es)
ZA (1) ZA828388B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115770B2 (en) * 1983-01-07 1996-06-19 Takeda Chemical Industries, Ltd. Thiazole Derivatives
GB8413152D0 (en) * 1983-06-03 1984-06-27 Ici Pharma Cephalosporin derivatives
US4855420A (en) * 1983-06-03 1989-08-08 Ici Pharma Cephalosporin derivatives
JPS6117589A (ja) * 1984-07-03 1986-01-25 Meiji Seika Kaisha Ltd 新規セフアロスポリン誘導体及びその製造法
JPS60178890A (ja) * 1984-02-23 1985-09-12 Meiji Seika Kaisha Ltd 新規セフアロスポリン誘導体およびその製造法
KR920004820B1 (ko) * 1984-02-23 1992-06-18 메이지제과 주식회사 새로운 세팔로스포린 유도체의 제조방법
FI851934L (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporinderivat.
US4868173A (en) * 1984-11-20 1989-09-19 Ici Pharma Cephalosporin derivatives
US4761410A (en) * 1985-01-14 1988-08-02 Fujisawa Pharmaceutical Co., Ltd. Cephem Compounds
US4645769A (en) * 1985-03-01 1987-02-24 Merck & Co., Inc. 1-oxa-1-dethia-cephalosporin compounds and antibacterial agent comprising the same
US4812562A (en) * 1985-07-25 1989-03-14 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPH064645B2 (ja) * 1985-11-27 1994-01-19 明治製菓株式会社 新規セフアロスポリン誘導体およびそれを含む抗菌剤
US5359057A (en) * 1986-02-07 1994-10-25 Hoffmann-La Roche Inc. Acylation of amines
US4880797A (en) * 1986-03-20 1989-11-14 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives and antibacterial agents
DE3782260T2 (de) * 1986-03-20 1993-05-06 Banyu Pharma Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und antibakterielle mittel.
JPS63154622A (ja) * 1986-12-18 1988-06-27 Meiji Seika Kaisha Ltd セフアロスポリン誘導体を有効成分とする哺乳動物用抗菌剤
WO1991005789A1 (en) * 1987-03-20 1991-05-02 Banyu Pharmaceutical Co., Ltd. 3-[(1-substituted pyridinium-4-yl)thiomethyl]-cephalosporin derivatives
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
WO2011103686A1 (en) * 2010-02-26 2011-09-01 Viswanatha , Sundaramma CEPHALOSPORIN DERIVATIVES USEFUL AS β-LACTAMASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
GB1603712A (en) * 1977-04-19 1981-11-25 Ciba Geigy Ag Process and dye preparations for pad-dyeing
AR231986A1 (es) * 1978-05-26 1985-04-30 Glaxo Group Ltd Procedimiento para preparar antibioticos de cefalosporina
GB1604724A (en) * 1978-05-26 1981-12-16 Glaxo Operations Ltd 7-(2-aminothiazol-4-yl)-2-oxymino-acedamido)-cephem derivatives
GB2027691B (en) * 1978-05-26 1983-03-02 Glaxo Group Ltd Cephalosporin antibiotics
GB1604723A (en) * 1978-05-26 1981-12-16 Glaxo Operations Ltd 7-(2-aminothiazol-4-yl)-2-oxyimino-acetamido)-cephem derivatives
BE880068A (fr) * 1978-11-17 1980-05-16 Glaxo Group Ltd Nouvelles cephalosporines et leur preparation
GB2036738B (en) * 1978-11-17 1983-01-19 Glaxo Group Ltd Cephalosporin antibiotics
GB2046261B (en) * 1979-03-22 1983-07-20 Glaxo Group Ltd Cephalosporin antibiotics
DE3011038A1 (de) * 1979-03-22 1980-11-27 Glaxo Group Ltd Cephalosporinantibiotika
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides

Also Published As

Publication number Publication date
EP0088853A1 (fr) 1983-09-21
MA19644A1 (fr) 1983-07-01
FR2516515B1 (es) 1984-11-23
PL244232A1 (en) 1984-06-18
NO823740L (no) 1983-05-18
PL239045A1 (en) 1984-02-27
HU187812B (en) 1986-02-28
OA07253A (fr) 1984-04-30
ES526001A0 (es) 1984-06-16
ZA828388B (en) 1983-10-26
ES8405806A1 (es) 1984-06-16
DK499382A (da) 1983-05-17
GR76748B (es) 1984-08-30
PL244233A1 (en) 1984-06-18
SU1165236A3 (ru) 1985-06-30
AU9049982A (en) 1983-05-26
SU1318145A3 (ru) 1987-06-15
PT75854A (fr) 1982-12-01
EP0088853B1 (fr) 1987-03-11
IE822665L (en) 1983-05-16
IL67208A0 (en) 1983-03-31
NZ202493A (en) 1985-11-08
CA1201432A (en) 1986-03-04
FI74710C (fi) 1988-03-10
PL136539B1 (en) 1986-02-28
KR840002407A (ko) 1984-07-21
EG15642A (en) 1986-09-30
JPS5890590A (ja) 1983-05-30
FI823917L (fi) 1983-05-17
SU1276263A3 (ru) 1986-12-07
DE3275649D1 (en) 1987-04-16
US4593022A (en) 1986-06-03
ES8405807A1 (es) 1984-06-16
FI74710B (fi) 1987-11-30
CS810682A2 (en) 1984-02-13
PL136099B1 (en) 1986-01-31
ES517393A0 (es) 1983-12-01
CS232740B2 (en) 1985-02-14
IE54068B1 (en) 1989-06-07
ES8401082A1 (es) 1983-12-01
FR2516515A1 (fr) 1983-05-20
AU566027B2 (en) 1987-10-08
KR880001816B1 (ko) 1988-09-19
SG2289G (en) 1989-06-02
FI823917A0 (fi) 1982-11-16
ATE25847T1 (de) 1987-03-15
YU253782A (en) 1984-12-31
PL136101B1 (en) 1986-01-31
ES526002A0 (es) 1984-06-16

Similar Documents

Publication Publication Date Title
IL67208A (en) Derivatives of 7-(2-(2-amino-4-thiazolyl)-2-oxyimino-acetamido)3-pyridinium thiomethyl-3-cephem-4-carboxylic acid,their preparation and pharmaceutical compositions containing them
NZ199875A (en) Cephalosporin derivatives and pharmaceutical compositions
IL67285A (en) 7-(2-(2-amino-4-thiazolyl)-2-oxyiminoacetamido)-3-cephem-3-heterocyclyl-thiomethyl-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ATE3550T1 (de) Kristalline salze eines cephalosporins, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.